Acurx Pharmaceuticals shareholders approve warrant exercise and share increase
PositiveFinancial Markets

Acurx Pharmaceuticals has received a green light from its shareholders to proceed with a warrant exercise and increase its share count. This decision is significant as it allows the company to raise additional capital, which can be crucial for funding ongoing research and development projects. The approval reflects shareholder confidence in Acurx's future prospects and its commitment to advancing innovative treatments.
— Curated by the World Pulse Now AI Editorial System